About

Changwei Ji is a urological surgeon and researcher whose work sits at the intersection of minimally invasive surgery, robotic-assisted techniques, and urologic oncology. His research has made significant contributions to the comparative evaluation of surgical approaches for adrenal tumors, renal cell carcinoma, and bladder cancer. Most notably, Ji has been a leading voice in advancing robot-assisted simple enucleation (RASE) as a viable and potentially superior alternative to standard partial nephrectomy for renal tumors — culminating in a landmark randomized controlled noninferiority trial, a rare and rigorous achievement in surgical research. His 2020 multicenter study on robotic versus laparoscopic adrenalectomy, which has garnered 41 citations, stands as one of the largest international collaborations in this area and has helped shape perioperative best practices globally. Across bladder cancer, complex ureteral strictures, and adrenal surgery, Ji consistently applies propensity score-matched analyses and multicenter datasets to produce clinically actionable findings. His growing citation record reflects a body of work that is reshaping how urologists select and refine minimally invasive surgical strategies, offering patients improved functional outcomes without compromising oncologic safety.

Research Focus

Key Achievements

6
H-Index
8
Papers
118
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative outcomes of robotic and laparoscopic adrenalectomy: a large international multicenter experience
41 citations · 2020
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Nanjing Drum Tower Hospital, Nanjing University, Nanjing Tech University, Nanjing University of Chinese Medicine

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago